The proton therapy research beamline at the Christie NHS foundation trust

Proton therapy is a relatively new modality for cancer treatment and has several open research questions, particularly in the biological realm. Due to large infrastructure costs the modality is reserved for specialist treatment, limiting the patient outcome dataset. This requires supplementation with fundamental research through<i>in vitro</i>and<i>in vivo</i>systems. Similarly, the safety and potential benefits of new treatments, such as FLASH, should be demonstrated in lab environments prior to clinical translation. Greater access to clinically relevant research platforms is required. This work presents the capabilities of the Manchester proton therapy research facility for experimentalists' assessment to meet their research goals. Details of the research beamline geometry are presented, along with workflows for<i>in vitro</i>sample irradiation within an automated sample handling environmental chamber. Absolute dose and dose depth of the proton research beamline was measured. The dose calibration across a range of energies and dose rates is presented and fits are mathematically described. Methods to convert measured, or planned, dose to sample dose are presented including for biological studies investigating end of proton range effects. Elements of the beam optics, impacting on spot size and therefore field homogeneity, were measured for sample irradiation and beam model development. A Monte Carlo beam model was established to predict physically difficult measurements and is compared to measurements throughout. Achievable dose rates for FLASH are presented alongside absolute dosimetric accuracy. There was a focus on radiobiological research in establishing the beamline. Special care was taken to develop high-throughput repeatable<i>in vitro</i>irradiation workflows, with an adjacent radiobiological lab for immediate processing. This will lead to a reduction in experimental uncertainties seen in the literature with demonstrated accurate dosimetry, tight environmental control, and a high degree of versatility. The infrastructure presented in this work is a unique facility in the UK.

Authors

Institutions

Publication Details

Journal
Biomedical Physics & Engineering Express
Published
2025-05-22
DOI
https://doi.org/10.1088/2057-1976/addbe8
Primary Topic
Radiation Therapy and Dosimetry
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The proton therapy research beamline at the Christie NHS foundation trust

Nicholas T. Henthorn, Ranald I. Mackay, K.J. Kirkby, Samuel Ingram et al.
Biomedical Physics & Engineering Express
Radiation Therapy and Dosimetry
article

The proton therapy research beamline at the Christie NHS foundation trust

Nicholas T. Henthorn, Ranald I. Mackay, K.J. Kirkby, Samuel Ingram, Michael J. Merchant, M. J. Taylor, John-William Warmenhoven, S. Manger
article en

Abstract

Proton therapy is a relatively new modality for cancer treatment and has several open research questions, particularly in the biological realm. Due to large infrastructure costs the modality is reserved for specialist treatment, limiting the patient outcome dataset. This requires supplementation with fundamental research through<i>in vitro</i>and<i>in vivo</i>systems. Similarly, the safety and potential benefits of new treatments, such as FLASH, should be demonstrated in lab environments prior to clinical translation. Greater access to clinically relevant research platforms is required. This work presents the capabilities of the Manchester proton therapy research facility for experimentalists' assessment to meet their research goals. Details of the research beamline geometry are presented, along with workflows for<i>in vitro</i>sample irradiation within an automated sample handling environmental chamber. Absolute dose and dose depth of the proton research beamline was measured. The dose calibration across a range of energies and dose rates is presented and fits are mathematically described. Methods to convert measured, or planned, dose to sample dose are presented including for biological studies investigating end of proton range effects. Elements of the beam optics, impacting on spot size and therefore field homogeneity, were measured for sample irradiation and beam model development. A Monte Carlo beam model was established to predict physically difficult measurements and is compared to measurements throughout. Achievable dose rates for FLASH are presented alongside absolute dosimetric accuracy. There was a focus on radiobiological research in establishing the beamline. Special care was taken to develop high-throughput repeatable<i>in vitro</i>irradiation workflows, with an adjacent radiobiological lab for immediate processing. This will lead to a reduction in experimental uncertainties seen in the literature with demonstrated accurate dosimetry, tight environmental control, and a high degree of versatility. The infrastructure presented in this work is a unique facility in the UK.

Biomedical Physics & Engineering ExpressVol. 11(4)
Cockcroft Institute (GB), Manchester Academic Health Science Centre (GB), Daresbury Laboratory (GB), University of Manchester (GB), The Christie NHS Foundation Trust (GB)
Cancer Research UK, Horizon 2020 Framework Programme, Manchester Biomedical Research Centre, Engineering and Physical Sciences Research Council, Science and Technology Facilities Council
Industry, innovation and infrastructure
Openalex Percentile: Top 81%
Radiation Therapy and Dosimetry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.